Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...
In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition known as hypoxia. Hypoxia arises as tumors grow rapidly, outpacing their ...
Tumor hypoxia refers to the gradual decrease in ATP production when oxygen levels drop below a critical threshold, contributing to malignant tumor development. Studies show hypoxia-induced changes ...
Tumour hypoxia drives resistance and aggressiveness, and in large part, contributes to treatment failure thereby causing cancer-related deaths. The rapid and uncontrolled tumour growth develops not ...
Despite major advances in targeted therapies, immunotherapies, and combination regimens, therapy resistance remains a central barrier to durable cancer ...
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study The following represents disclosure ...
Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each ...
The field of multifunctional nanomaterials stands at the forefront of Cancer Therapy and Tissue Regeneration. Diseases such ...
Prostate cancer is one of the most prevalent malignancies in men and remains a leading cause of cancer-related morbidity and mortality worldwide. For many, prostate cancer follows an indolent course, ...
Sixteen genes help cancer cells leave the low-oxygen region of tumors and survive in the bloodstream. One – MUC1 (purple) – is in clinical trials to reduce cancer recurrence. Scientists at the Johns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results